Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Eur Heart J Cardiovasc Pharmacother
; 10(4): 342-352, 2024 Jul 16.
Article
in En
| MEDLINE
| ID: mdl-38658193
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
/
PCSK9 Inhibitors
/
Cholesterol, LDL
Limits:
Humans
Language:
En
Journal:
Eur Heart J Cardiovasc Pharmacother
Year:
2024
Document type:
Article
Affiliation country:
Country of publication: